Akebia Therapeutics
AKBA
#9599
Rank
C$0.15 B
Marketcap
C$0.56
Share price
-7.79%
Change (1 day)
-75.00%
Change (1 year)

EPS for Akebia Therapeutics (AKBA)

EPS in 2026 (TTM): C-$0.22

According to Akebia Therapeutics's latest financial reports the company's current EPS (TTM) is C-$0.23. In 2025 the company made an earnings per share (EPS) of C-$0.02867 an increase over its 2024 EPS that were of C-$0.47.

EPS history for Akebia Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$0.22681.35%
2025C-$0.02867-93.94%
2024C-$0.47-16.83%
2023C-$0.57-23.7%
2022C-$0.75-69.41%
2021C-$2.44-38.63%
2020C-$3.9717.37%
2019C-$3.382.79%
2018C-$3.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.57-4,274.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$7.52-3,381.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
C$24.91-10,962.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
C-$9.60 4,087.50%๐Ÿ‡บ๐Ÿ‡ธ USA